{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:36:24Z","timestamp":1791336984375,"version":"4.3.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thoracic (pulmonary and thymic) neuroendocrine tumors are well-differentiated epithelial neuroendocrine neoplasms that are classified into typical and atypical carcinoid tumors based on mitotic index cut offs and presence or absence of necrosis. This classification scheme is of great prognostic value but designed for surgical specimens, only. Deep molecular characterization of thoracic neuroendocrine tumors highlighted their difference with neuroendocrine carcinomas. Neuroendocrine tumors of the lung are characterized by a low mutational burden, and a high prevalence of mutations in chromatin remodeling and histone modification-related genes, whereas mutations in genes frequently altered in neuroendocrine carcinomas are rare. Molecular profiling divided thymic neuroendocrine tumors into three clusters with distinct clinical outcomes and characterized by a different average of copy number instability. Moreover, integrated histopathological, molecular and clinical evidence supports the existence of a grey zone category between neuroendocrine tumors (carcinoid tumors) and neuroendocrine carcinomas. Indeed, cases with well differentiated morphology but mitotic\/Ki-67 indexes close to neuroendocrine carcinomas have been increasingly recognized. These are characterized by specific molecular profiles and have an aggressive clinical behavior. Finally, thoracic neuroendocrine tumors may arise in the background of genetic susceptibility, being MEN1 syndrome the well-defined familial form. However, pathologists should be aware of rarer germline variants that are associated with the concurrence of neuroendocrine tumors of the lung or their precursors (such as DIPNECH) with other neoplasms, including but not limited to breast carcinomas. Therefore, genetic counseling for all young patients with thoracic neuroendocrine neoplasia and\/or any patient with pathological evidence of neuroendocrine cell hyperplasia-to-neoplasia progression sequence or multifocal disease should be considered.<\/jats:p>","DOI":"10.1007\/s12022-021-09668-z","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T17:03:11Z","timestamp":1614445391000},"page":"154-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know?"],"prefix":"10.1007","volume":"32","author":[{"given":"Marco","family":"Volante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja C.","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst Jan M.","family":"Speel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Uccella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"key":"9668_CR1","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB (2008) One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063-72. doi: https:\/\/doi.org\/10.1200\/JCO.2007.15.4377","journal-title":"J Clin Oncol"},{"key":"9668_CR2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.athoracsur.2018.05.044","volume":"106","author":"PJ Kneuertz","year":"2018","unstructured":"Kneuertz PJ, Kamel MK, Stiles BM, Lee BE, Rahouma M, Harrison SW, Altorki NK, Port JL (2018) Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases. Ann Thorac Surg 106:981-988. doi: https:\/\/doi.org\/10.1016\/j.athoracsur.2018.05.044","journal-title":"Ann Thorac Surg"},{"key":"9668_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s12094-017-1759-2","volume":"20","author":"O Abdel-Rahman","year":"2018","unstructured":"Abdel-Rahman O (2018) Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system. Clin Transl Oncol 20:670-677. doi: https:\/\/doi.org\/10.1007\/s12094-017-1759-2","journal-title":"Clin Transl Oncol"},{"key":"9668_CR4","doi-asserted-by":"publisher","unstructured":"Dermawan JK, Farver CF (2019) The Prognostic Significance of the 8th Edition TNM Staging of Pulmonary Carcinoid Tumors: A Single Institution Study With Long-term Follow-up. Am J Surg Pathol 43:1291\u20131296. doi: https:\/\/doi.org\/10.1097\/PAS.0000000000001268","DOI":"10.1097\/PAS.0000000000001268"},{"key":"9668_CR5","doi-asserted-by":"publisher","first-page":"S1458","DOI":"10.21037\/jtd.2017.03.82","volume":"9","author":"IM Modlin","year":"2017","unstructured":"Modlin IM, Kidd M, Filosso PL, Roffinella M, Lewczuk A, Cwikla J, Bodei L, Kolasinska-Cwikla A, Chung KM, Tesselaar ME, Drozdov IA (2017) Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasms. J Thorac Dis 9:S1458-S1473. doi: https:\/\/doi.org\/10.21037\/jtd.2017.03.82","journal-title":"J Thorac Dis"},{"key":"9668_CR6","volume-title":"WHO Classification of Tumours of the Lung, Pleura","author":"W Travis","year":"2015","unstructured":"Travis W, Brambilla E, Burke A, Marx A, Nicholson A. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, Lyon, 2015"},{"key":"9668_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jtho.2019.02.002","volume":"14","author":"P Robelin","year":"2019","unstructured":"Robelin P, Hadoux J, Forestier J, Planchard D, Hervieu V, Berdelou A, Scoazec JY, Valette PJ, Leboulleux S, Ducreux M, Lombard-Bohas C, Baudin E, Walter T (2019) Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors. J Thorac Oncol 14:993-1002. doi: https:\/\/doi.org\/10.1016\/j.jtho.2019.02.002","journal-title":"J Thorac Oncol"},{"key":"9668_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.humpath.2020.02.005","volume":"98","author":"CA Moran","year":"2020","unstructured":"Moran CA, Lindholm KE, Brunnstr\u00f6m H, Langman G, Jang SJ, Spagnolo D, Chai SM, Laycock A, Falconieri G, Pizzolitto S, de Pellegrin A, Medeiros F, Edmunds L, Catarino A, Cunha F, Ro J, Pina-Oviedo S, Torrealba J, Coppola D, Petersson F, Oon ML, Elmberger G, Y Cajal SR, Valero IS, Dalurzo L, Soares F, Campos AH, Vranic S, Skenderi F, Correa AM, Sepesi B, Rice D, Mehran R, Walsh G (2020) Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features. Hum Pathol 98:98-109. doi: https:\/\/doi.org\/10.1016\/j.humpath.2020.02.005","journal-title":"Hum Pathol"},{"key":"9668_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/ERC-13-0246","volume":"21","author":"G Rindi","year":"2013","unstructured":"Rindi G, Klersy C, Inzani F, Fellegara G, Ampollini L, Ardizzoni A, Campanini N, Carbognani P, De Pas TM, Galetta D, Granone PL, Righi L, Rusca M, Spaggiari L, Tiseo M, Viale G, Volante M, Papotti M, Pelosi G (2013) Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer 21:1-16. doi: https:\/\/doi.org\/10.1530\/ERC-13-0246","journal-title":"Endocr Relat Cancer"},{"key":"9668_CR10","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41379-018-0076-9","volume":"31","author":"AM Marchevsky","year":"2018","unstructured":"Marchevsky AM, Hendifar A, Walts AE (2018) The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence. Mod Pathol 31:1523-1531. doi: https:\/\/doi.org\/10.1038\/s41379-018-0076-9","journal-title":"Mod Pathol"},{"key":"9668_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/PAS.0000000000001358","volume":"44","author":"JKT Dermawan","year":"2020","unstructured":"Dermawan JKT, Farver CF (2020) The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors. Am J Surg Pathol 44:224-231. doi: https:\/\/doi.org\/10.1097\/PAS.0000000000001358.","journal-title":"Am J Surg Pathol"},{"key":"9668_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00428-017-2177-0","volume":"471","author":"C Marchi\u00f2","year":"2017","unstructured":"Marchi\u00f2 C, Gatti G, Massa F, Bertero L, Filosso P, Pelosi G, Cassoni P, Volante M, Papotti M (2017) Distinctive pathological and clinical features of lung carcinoids with high proliferation index. Virchows Arch 471:713-720. doi: https:\/\/doi.org\/10.1007\/s00428-017-2177-0","journal-title":"Virchows Arch"},{"key":"9668_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000495806","volume":"108","author":"A Kasajima","year":"2019","unstructured":"Kasajima A, Konukiewitz B, Oka N, Suzuki H, Sakurada A, Okada Y, Kameya T, Ishikawa Y, Sasano H, Weichert W, Kl\u00f6ppel G (2019) Clinicopathological Profiling of Lung Carcinoids with a Ki67 Index > 20. Neuroendocrinology 108:109-120. doi: https:\/\/doi.org\/10.1159\/000495806","journal-title":"Neuroendocrinology"},{"key":"9668_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.lungcan.2020.08.001","volume":"148","author":"M Rubino","year":"2020","unstructured":"Rubino M, Scoazec JY, Pisa E, Faron M, Spaggiari L, Hadoux J, Spada F, Planchard D, Cella CA, Leboulleux S, De Marinis F, Ducreux M, Lamartina L, Baudin E, Fazio N (2020) Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms. Lung Cancer 148:149-158. doi: https:\/\/doi.org\/10.1016\/j.lungcan.2020.08.001","journal-title":"Lung Cancer"},{"key":"9668_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.lungcan.2020.10.015","volume":"150","author":"BCM Hermans","year":"2020","unstructured":"Hermans BCM, Derks JL, Moonen L, Habraken CHJ, der Th\u00fcsen JV, Hillen LM, Speel EJM, Dingemans AC (2020) Pulmonary neuroendocrine neoplasms with well differentiated morphology and high proliferative activity: illustrated by a case series and review of the literature. Lung Cancer 150:152-158. doi: https:\/\/doi.org\/10.1016\/j.lungcan.2020.10.015","journal-title":"Lung Cancer"},{"key":"9668_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/PAS.0000000000000767","volume":"41","author":"AM Quinn","year":"2017","unstructured":"Quinn AM, Chaturvedi A, Nonaka D (2017) High-grade Neuroendocrine Carcinoma of the Lung With Carcinoid Morphology: A Study of 12 Cases. Am J Surg Pathol 41:263-270. doi: https:\/\/doi.org\/10.1097\/PAS.0000000000000767","journal-title":"Am J Surg Pathol"},{"key":"9668_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/LBR.0000000000000147","volume":"22","author":"S Ie","year":"2015","unstructured":"Ie S, Boyd M (2015) New cancer or carcinoid progression to small cell lung cancer? J Bronchology Interv Pulmonol 22:186-8. doi: https:\/\/doi.org\/10.1097\/LBR.0000000000000147","journal-title":"J Bronchology Interv Pulmonol"},{"key":"9668_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00428-018-2307-3","volume":"472","author":"G Pelosi","year":"2018","unstructured":"Pelosi G, Bianchi F, Dama E, Simbolo M, Mafficini A, Sonzogni A, Pilotto S, Harari S, Papotti M, Volante M, Fontanini G, Mastracci L, Albini A, Bria E, Calabrese F, Scarpa A (2018) Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm. Virchows Arch 472:567-577. doi: https:\/\/doi.org\/10.1007\/s00428-018-2307-3","journal-title":"Virchows Arch"},{"key":"9668_CR19","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.jtho.2019.04.015","volume":"14","author":"H Dinter","year":"2019","unstructured":"Dinter H, Bohnenberger H, Beck J, Bornemann-Kolatzki K, Sch\u00fctz E, K\u00fcffer S, Klein L, Franks TJ, Roden A, Emmert A, Hinterthaner M, Marino M, Brcic L, Popper H, Weis CA, Pelosi G, Marx A, Str\u00f6bel P (2019) Molecular Classification of Neuroendocrine Tumors of the Thymus. J Thorac Oncol 14:1472-1483. doi: https:\/\/doi.org\/10.1016\/j.jtho.2019.04.015","journal-title":"J Thorac Oncol"},{"key":"9668_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00428-017-2130-2","volume":"471","author":"A Fabbri","year":"2017","unstructured":"Fabbri A, Cossa M, Sonzogni A, Bidoli P, Canova S, Cortinovis D, Abbate MI, Calabrese F, Nannini N, Lunardi F, Rossi G, La Rosa S, Capella C, Tamborini E, Perrone F, Busico A, Capone I, Valeri B, Pastorino U, Albini A, Pelosi G (2017) Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed \u00df-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift. Virchows Arch 471:31-47. doi: https:\/\/doi.org\/10.1007\/s00428-017-2130-2","journal-title":"Virchows Arch"},{"key":"9668_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/14737159.2019.1595593","volume":"19","author":"G Pelosi","year":"2019","unstructured":"Pelosi G, Bianchi F, Hofman P, Pattini L, Str\u00f6bel P, Calabrese F, Naheed S, Holden C, Cave J, Bohnenberger H, Dinter H, Harari S, Albini A, Sonzogni A, Papotti M, Volante M, Ottensmeier CH (2019) Recent advances in the molecular landscape of lung neuroendocrine tumors. Expert Rev Mol Diagn 19:281-297. doi: https:\/\/doi.org\/10.1080\/14737159.2019.1595593","journal-title":"Expert Rev Mol Diagn"},{"key":"9668_CR22","doi-asserted-by":"publisher","first-page":"R417","DOI":"10.1530\/ERC-20-0122","volume":"27","author":"A Kasajima","year":"2020","unstructured":"Kasajima A, Kl\u00f6ppel G (2020) Neuroendocrine neoplasms of lung, pancreas and gut: a morphology-based comparison. Endocr Relat Cancer 27:R417-R432. doi: https:\/\/doi.org\/10.1530\/ERC-20-0122","journal-title":"Endocr Relat Cancer"},{"key":"9668_CR23","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jtho.2018.02.002","volume":"13","author":"JL Derks","year":"2018","unstructured":"Derks JL, Leblay N, Lantuejoul S, Dingemans AC, Speel EM, Fernandez-Cuesta L (2018) New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management. J Thorac Oncol 13:752-766. doi: https:\/\/doi.org\/10.1016\/j.jtho.2018.02.002","journal-title":"J Thorac Oncol"},{"key":"9668_CR24","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1038\/ncomms4518","volume":"5","author":"L Fernandez-Cuesta","year":"2014","unstructured":"Fernandez-Cuesta L, Peifer M, Lu X, Sun R, Ozreti\u0107 L, Seidal D, Zander T, Leenders F, George J, M\u00fcller C, Dahmen I, Pinther B, Bosco G, Konrad K, Altm\u00fcller J, N\u00fcrnberg P, Achter V, Lang U, Schneider PM, Bogus M, Soltermann A, Brustugun OT, Helland \u00c5, Solberg S, Lund-Iversen M, Ans\u00e9n S, Stoelben E, Wright GM, Russell P, Wainer Z, Solomon B, Field JK, Hyde R, Davies MP, Heukamp LC, Petersen I, Perner S, Lovly C, Cappuzzo F, Travis WD, Wolf J, Vingron M, Brambilla E, Haas SA, Buettner R, Thomas RK (2014) Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nat Commun 5:3518. doi: https:\/\/doi.org\/10.1038\/ncomms4518","journal-title":"Nat Commun"},{"key":"9668_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/path.4853","volume":"241","author":"M Simbolo","year":"2017","unstructured":"Simbolo M, Mafficini A, Sikora KO, Fassan M, Barbi S, Corbo V, Mastracci L, Rusev B, Grillo F, Vicentini C, Ferrara R, Pilotto S, Davini F, Pelosi G, Lawlor RT, Chilosi M, Tortora G, Bria E, Fontanini G, Volante M, Scarpa A (2017) Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D. J Pathol 241:488-500. doi: https:\/\/doi.org\/10.1002\/path.4853","journal-title":"J Pathol"},{"key":"9668_CR26","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-19-0214","volume":"79","author":"SV Laddha","year":"2019","unstructured":"Laddha SV, da Silva EM, Robzyk K, Untch BR, Ke H, Rekhtman N, Poirier JT, Travis WD, Tang LH, Chan CS (2019) Integrative Genomic Characterization Identifies Molecular Subtypes of Lung Carcinoids. Cancer Res 79:4339-4347. doi: https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0214","journal-title":"Cancer Res"},{"key":"9668_CR27","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1038\/s41467-019-11276-9","volume":"10","author":"N Alcala","year":"2019","unstructured":"Alcala N, Leblay N, Gabriel AAG, Mangiante L, Hervas D, Giffon T, Sertier AS, Ferrari A, Derks J, Ghantous A, Delhomme TM, Chabrier A, Cuenin C, Abedi-Ardekani B, Boland A, Olaso R, Meyer V, Altmuller J, Le Calvez-Kelm F, Durand G, Voegele C, Boyault S, Moonen L, Lemaitre N, Lorimier P, Toffart AC, Soltermann A, Clement JH, Saenger J, Field JK, Brevet M, Blanc-Fournier C, Galateau-Salle F, Le Stang N, Russell PA, Wright G, Sozzi G, Pastorino U, Lacomme S, Vignaud JM, Hofman V, Hofman P, Brustugun OT, Lund-Iversen M, Thomas de Montpreville V, Muscarella LA, Graziano P, Popper H, Stojsic J, Deleuze JF, Herceg Z, Viari A, Nuernberg P, Pelosi G, Dingemans AMC, Milione M, Roz L, Brcic L, Volante M, Papotti MG, Caux C, Sandoval J, Hernandez-Vargas H, Brambilla E, Speel EJM, Girard N, Lantuejoul S, McKay JD, Foll M, Fernandez-Cuesta L (2019) Integrative and comparative genomic analyses identify clinically\u00a0relevant pulmonary carcinoid\u00a0groups and unveil the supra-carcinoids. Nat Commun 10:3407. doi: https:\/\/doi.org\/10.1038\/s41467-019-11276-9","journal-title":"Nat Commun"},{"key":"9668_CR28","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1158\/1078-0432.CCR-17-0252","volume":"24","author":"MK Asiedu","year":"2018","unstructured":"Asiedu MK, Thomas CF Jr, Dong J, Schulte SC, Khadka P, Sun Z, Kosari F, Jen J, Molina J, Vasmatzis G, Kuang R, Aubry MC, Yang P, Wigle DA (2018) Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors. Clin Cancer Res 24:1691-1704. doi: https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0252","journal-title":"Clin Cancer Res"},{"key":"9668_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.lungcan.2020.03.027","volume":"145","author":"A Miyanaga","year":"2020","unstructured":"Miyanaga A, Masuda M, Motoi N, Tsuta K, Nakamura Y, Nishijima N, Watanabe SI, Asamura H, Tsuchida A, Seike M, Gemma A, Yamada T (2020) Whole-exome and RNA sequencing of pulmonary carcinoid reveals chromosomal rearrangements associated with recurrence. Lung Cancer 145:85-94. doi: https:\/\/doi.org\/10.1016\/j.lungcan.2020.03.027","journal-title":"Lung Cancer"},{"key":"9668_CR30","doi-asserted-by":"publisher","unstructured":"Gabriel AAG, Mathian E, Mangiante L, Voegele C, Cahais V, Ghantous A, McKay JD, Alcala N, Fernandez-Cuesta L, Foll M (2020) A molecular map of lung neuroendocrine neoplasms. Gigascience 9:giaa112. doi: https:\/\/doi.org\/10.1093\/gigascience\/giaa112","DOI":"10.1093\/gigascience\/giaa112"},{"key":"9668_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9440(10)65289-3","volume":"154","author":"B G\u00f6rtz","year":"1999","unstructured":"G\u00f6rtz B, Roth J, Kr\u00e4henmann A, de Krijger RR, Muletta-Feurer S, R\u00fctimann K, Saremaslani P, Speel EJ, Heitz PU, Komminoth P (1999) Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. Am J Pathol 154:429-36. doi: https:\/\/doi.org\/10.1016\/S0002-9440(10)65289-3","journal-title":"Am J Pathol"},{"key":"9668_CR32","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3892\/ijo.2012.1563","volume":"41","author":"S Veschi","year":"2012","unstructured":"Veschi S, Lattanzio R, Aceto GM, Curia MC, Magnasco S, Angelucci D, Cama A, Piantelli M, Battista P (2012) Alterations of MEN1 and E-cadherin\/\u03b2-catenin complex in sporadic pulmonary carcinoids. Int J Oncol 41:1221-8. doi: https:\/\/doi.org\/10.3892\/ijo.2012.1563","journal-title":"Int J Oncol"},{"key":"9668_CR33","doi-asserted-by":"publisher","first-page":"E374","DOI":"10.1210\/jc.2013-2782","volume":"99","author":"DR Swarts","year":"2014","unstructured":"Swarts DR, Scarpa A, Corbo V, Van Criekinge W, van Engeland M, Gatti G, Henfling ME, Papotti M, Perren A, Ramaekers FC, Speel EJ, Volante M (2014) MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids. J Clin Endocrinol Metab 99:E374-8. doi: https:\/\/doi.org\/10.1210\/jc.2013-2782","journal-title":"J Clin Endocrinol Metab"},{"key":"9668_CR34","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3892\/or.2012.2017","volume":"28","author":"A Capodanno","year":"2012","unstructured":"Capodanno A, Boldrini L, Al\u00ec G, Pelliccioni S, Mussi A, Fontanini G (2012) Phosphatidylinositol-3-kinase \u03b1 catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours. Oncol Rep 28:1559-66. doi: https:\/\/doi.org\/10.3892\/or.2012.2017","journal-title":"Oncol Rep"},{"key":"9668_CR35","doi-asserted-by":"publisher","unstructured":"Centonze G, Biganzoli D, Prinzi N, Pusceddu S, Mangogna A, Tamborini E, Perrone F, Busico A, Lagano V, Cattaneo L, Sozzi G, Roz L, Biganzoli E, Milione M (2020) Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined Groups. Cancers (Basel) 12:2753. doi: https:\/\/doi.org\/10.3390\/cancers12102753","DOI":"10.3390\/cancers12102753"},{"key":"9668_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature21063","volume":"543","author":"A Scarpa","year":"2017","unstructured":"Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, Rusev B, Scardoni M, Antonello D, Barbi S, Sikora KO, Cingarlini S, Vicentini C, McKay S, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, McLean S, Nourse C, Nourbakhsh E, Wilson PJ, Anderson MJ, Fink JL, Newell F, Waddell N, Holmes O, Kazakoff SH, Leonard C, Wood S, Xu Q, Nagaraj SH, Amato E, Dalai I, Bersani S, Cataldo I, Dei Tos AP, Capelli P, Dav\u00ec MV, Landoni L, Malpaga A, Miotto M, Whitehall VL, Leggett BA, Harris JL, Harris J, Jones MD, Humphris J, Chantrill LA, Chin V, Nagrial AM, Pajic M, Scarlett CJ, Pinho A, Rooman I, Toon C, Wu J, Pinese M, Cowley M, Barbour A, Mawson A, Humphrey ES, Colvin EK, Chou A, Lovell JA, Jamieson NB, Duthie F, Gingras MC, Fisher WE, Dagg RA, Lau LM, Lee M, Pickett HA, Reddel RR, Samra JS, Kench JG, Merrett ND, Epari K, Nguyen NQ, Zeps N, Falconi M, Simbolo M, Butturini G, Van Buren G, Partelli S, Fassan M; Australian Pancreatic Cancer Genome Initiative, Khanna KK, Gill AJ, Wheeler DA, Gibbs RA, Musgrove EA, Bassi C, Tortora G, Pederzoli P, Pearson JV, Waddell N, Biankin AV, Grimmond SM (2017) Whole-genome landscape of pancreatic neuroendocrine tumours. Nature 543:65-71. doi: https:\/\/doi.org\/10.1038\/nature21063","journal-title":"Nature"},{"key":"9668_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.humpath.2019.08.022","volume":"94","author":"S Terra","year":"2019","unstructured":"Terra S, Xie H, Boland JM, Mansfield AS, Molina JR, Roden AC (2019) Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors. Hum Pathol 94:78-85. doi: https:\/\/doi.org\/10.1016\/j.humpath.2019.08.022","journal-title":"Hum Pathol"},{"key":"9668_CR38","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1634\/theoncologist.2017-0054","volume":"22","author":"VE Wang","year":"2017","unstructured":"Wang VE, Young L, Ali S, Miller VA, Urisman A, Wolfe J, Bivona TG, Damato B, Fogh S, Bergsland EK (2017) A Case of Metastatic Atypical Neuroendocrine Tumor with\u00a0ALK\u00a0Translocation and Diffuse Brain Metastases. Oncologist 22:768-773. doi: https:\/\/doi.org\/10.1634\/theoncologist.2017-0054","journal-title":"Oncologist"},{"key":"9668_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.lungcan.2020.05.019","volume":"146","author":"JL Leal","year":"2020","unstructured":"Leal JL, Peters G, Szaumkessel M, Leong T, Asadi K, Rivalland G, Do H, Senko C, Mitchell PL, Quing CZ, Dobrovic A, Thapa B, John T (2020) NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer. Lung Cancer 146:154-159. doi: https:\/\/doi.org\/10.1016\/j.lungcan.2020.05.019","journal-title":"Lung Cancer"},{"key":"9668_CR40","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/his.13388","volume":"72","author":"D Hoton","year":"2018","unstructured":"Hoton D, Humblet Y, Libbrecht L (2018) Phenotypic variation of an ALK-positive large-cell neuroendocrine lung carcinoma with carcinoid morphology during treatment with ALK inhibitors. Histopathology 72:707-710. doi: https:\/\/doi.org\/10.1111\/his.13388","journal-title":"Histopathology"},{"key":"9668_CR41","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41379-019-0248-2","volume":"32","author":"N Rekhtman","year":"2019","unstructured":"Rekhtman N, Desmeules P, Litvak AM, Pietanza MC, Santos-Zabala ML, Ni A, Montecalvo J, Chang JC, Beras A, Preeshagul IR, Sabari JK, Rudin CM, Ladanyi M, Klimstra DS, Travis WD, Lai WC (2019) Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices. Mod Pathol 32:1106-1122. doi: https:\/\/doi.org\/10.1038\/s41379-019-0248-2","journal-title":"Mod Pathol"},{"key":"9668_CR42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000506292","volume":"111","author":"J Cros","year":"2021","unstructured":"Cros J, Th\u00e9ou-Anton N, Gounant V, Nicolle R, Reyes C, Humez S, Hescot S, Thomas de Montpr\u00e9ville V, Guy\u00e9tant S, Scoazec JY, Guyard A, de Mestier L, Brosseau S, Mordant P, Castier Y, Gentien D, Ruszniewski P, Zalcman G, Couvelard A, Cazes A (2021) Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology. Neuroendocrinology 111:158-169. doi: https:\/\/doi.org\/10.1159\/000506292","journal-title":"Neuroendocrinology"},{"key":"9668_CR43","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/bjc.2014.41","volume":"110","author":"F Toffalorio","year":"2014","unstructured":"Toffalorio F, Belloni E, Barberis M, Bucci G, Tizzoni L, Pruneri G, Fumagalli C, Spitaleri G, Catania C, Melotti F, Pelicci PG, Spaggiari L, De Pas T (2014) Gene expression profiling reveals GC and CEACAM1 as new tools in the diagnosis of lung carcinoids. Br J Cancer 110:1244-9. doi: https:\/\/doi.org\/10.1038\/bjc.2014.41","journal-title":"Br J Cancer"},{"key":"9668_CR44","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1093\/carcin\/bgt271","volume":"34","author":"DR Swarts","year":"2013","unstructured":"Swarts DR, Van Neste L, Henfling ME, Eijkenboom I, Eijk PP, van Velthuysen ML, Vink A, Volante M, Ylstra B, Van Criekinge W, van Engeland M, Ramaekers FC, Speel EJ (2013) An exploration of pathways involved in lung carcinoid progression using gene expression profiling. Carcinogenesis 34:2726-37. doi: https:\/\/doi.org\/10.1093\/carcin\/bgt271","journal-title":"Carcinogenesis"},{"key":"9668_CR45","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1158\/1078-0432.CCR-12-3078","volume":"19","author":"DR Swarts","year":"2013","unstructured":"Swarts DR, Henfling ME, Van Neste L, van Suylen RJ, Dingemans AM, Dinjens WN, Haesevoets A, Rudelius M, Thunnissen E, Volante M, Van Criekinge W, van Engeland M, Ramaekers FC, Speel EJ (2013) CD44 and OTP are strong prognostic markers for pulmonary carcinoids. Clin Cancer Res 19:2197-207. doi: https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3078","journal-title":"Clin Cancer Res"},{"key":"9668_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12022-016-9459-y","volume":"28","author":"G Papaxoinis","year":"2017","unstructured":"Papaxoinis G, Nonaka D, O'Brien C, Sanderson B, Krysiak P, Mansoor W (2017) Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours. Endocr Pathol 28:60-70. doi: https:\/\/doi.org\/10.1007\/s12022-016-9459-y","journal-title":"Endocr Pathol"},{"key":"9668_CR47","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/cancers11101508","volume":"11","author":"L Moonen","year":"2019","unstructured":"Moonen L, Derks J, Dingemans AM, Speel EJ (2019) Orthopedia Homeobox (OTP) in Pulmonary Neuroendocrine Tumors: The Diagnostic Value and Possible Molecular Interactions. Cancers (Basel) 11:1508. doi: https:\/\/doi.org\/10.3390\/cancers11101508.","journal-title":"Cancers (Basel)"},{"key":"9668_CR48","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.jtho.2019.05.003","volume":"14","author":"M Simbolo","year":"2019","unstructured":"Simbolo M, Barbi S, Fassan M, Mafficini A, Ali G, Vicentini C, Sperandio N, Corbo V, Rusev B, Mastracci L, Grillo F, Pilotto S, Pelosi G, Pelliccioni S, Lawlor RT, Tortora G, Fontanini G, Volante M, Scarpa A, Bria E (2019) Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations. J Thorac Oncol 14:1651-1661. doi: https:\/\/doi.org\/10.1016\/j.jtho.2019.05.003","journal-title":"J Thorac Oncol"},{"key":"9668_CR49","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41379-020-0538-8","volume":"33","author":"O Sazonova","year":"2020","unstructured":"Sazonova O, Manem V, Orain M, Khoshkrood-Mansoori B, Gaudreault N, Desmeules P, Boss\u00e9 Y, Joubert P (2020) Transcriptomic data helps refining classification of pulmonary carcinoid tumors with increased mitotic counts. Mod Pathol 33:1712-1721. doi: https:\/\/doi.org\/10.1038\/s41379-020-0538-8","journal-title":"Mod Pathol"},{"key":"9668_CR50","first-page":"4269","volume":"30","author":"G Pelosi","year":"2010","unstructured":"Pelosi G, Fumagalli C, Trubia M, Sonzogni A, Rekhtman N, Maisonneuve P, Galetta D, Spaggiari L, Veronesi G, Scarpa A, Malpeli G, Viale G (2010) Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung. Anticancer Res 30:4269-81. Doi not available","journal-title":"Anticancer Res"},{"key":"9668_CR51","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1038\/sj.onc.1204798","volume":"20","author":"L Chaussade","year":"2001","unstructured":"Chaussade L, Eymin B, Brambilla E, Gazzeri S (2001) Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Oncogene 20:6587-96. doi: https:\/\/doi.org\/10.1038\/sj.onc.1204798","journal-title":"Oncogene"},{"key":"9668_CR52","doi-asserted-by":"publisher","first-page":"6977","DOI":"10.2147\/OTT.S117161","volume":"9","author":"X Yang","year":"2016","unstructured":"Yang X, Yang L, Dai W, Ye B (2016) Role of p14ARF and p15INK4B promoter methylation in patients with lung cancer: a systematic meta-analysis. Onco Targets Ther 9:6977-6985. doi: https:\/\/doi.org\/10.2147\/OTT.S117161","journal-title":"Onco Targets Ther"},{"key":"9668_CR53","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.5301\/JBM.2012.9766","volume":"27","author":"A la Torre","year":"2012","unstructured":"la Torre A, Muscarella LA, Parrella P, Balsamo T, Bisceglia M, Valori VM, la Torre A, Barbano R, Perrella E, Poeta ML, Melchionda G, Merla G, Maiello E, Pellicano R, Fazio VM (2012) Aberrant genes promoter methylation in neural crest-derived tumors. Int J Biol Markers 27:e389-94. doi: https:\/\/doi.org\/10.5301\/JBM.2012.9766","journal-title":"Int J Biol Markers"},{"key":"9668_CR54","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3390\/ijms20102531","volume":"20","author":"A Sparaneo","year":"2019","unstructured":"Sparaneo A, Fabrizio FP, la Torre A, Graziano P, Di Maio M, Fontana A, Bisceglia M, Rossi A, Pizzolitto S, De Maglio G, Tancredi A, Grimaldi F, Balsamo T, Centra F, Manzorra MC, Trombetta D, Pantalone A, Bonfitto A, Maiello E, Fazio VM, Muscarella LA (2019) Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors. Int J Mol Sci 20:2531. doi: https:\/\/doi.org\/10.3390\/ijms20102531","journal-title":"Int J Mol Sci"},{"key":"9668_CR55","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.3390\/ijms20112697","volume":"20","author":"FP Fabrizio","year":"2019","unstructured":"Fabrizio FP, Sparaneo A, Centra F, Trombetta D, Storlazzi CT, Graziano P, Maiello E, Fazio VM, Muscarella LA (2019) Methylation Density Pattern of KEAP1 Gene in Lung Cancer Cell Lines Detected by Quantitative Methylation Specific PCR and Pyrosequencing. Int J Mol Sci 20:2697. doi: https:\/\/doi.org\/10.3390\/ijms20112697","journal-title":"Int J Mol Sci"},{"key":"9668_CR56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1746-1596-8-201","volume":"8","author":"K Shilo","year":"2013","unstructured":"Shilo K, Wu X, Sharma S, Welliver M, Duan W, Villalona-Calero M, Fukuoka J, Sif S, Baiocchi R, Hitchcock CL, Zhao W, Otterson GA (2013) Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors. Diagn Pathol 8:201. doi: https:\/\/doi.org\/10.1186\/1746-1596-8-201","journal-title":"Diagn Pathol"},{"key":"9668_CR57","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.humpath.2010.09.019","volume":"42","author":"JJ Findeis-Hosey","year":"2011","unstructured":"Findeis-Hosey JJ, Huang J, Li F, Yang Q, McMahon LA, Xu H (2011) High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not. Hum Pathol 42:867-72. doi: https:\/\/doi.org\/10.1016\/j.humpath.2010.09.019","journal-title":"Hum Pathol"},{"key":"9668_CR58","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/PAI.0b013e3182108e2e","volume":"19","author":"F Li","year":"2011","unstructured":"Li F, Ye B, Hong L, Xu H, Fishbein MC (2011) Epigenetic modifications of histone h4 in lung neuroendocrine tumors. Appl Immunohistochem Mol Morphol 19:389-94. doi: https:\/\/doi.org\/10.1097\/PAI.0b013e3182108e2e","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"9668_CR59","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/modpathol.2014.74","volume":"27","author":"FD Mairinger","year":"2014","unstructured":"Mairinger FD, Ting S, Werner R, Walter RF, Hager T, Vollbrecht C, Christoph D, Worm K, Mairinger T, Sheu-Grabellus SY, Theegarten D, Schmid KW, Wohlschlaeger J (2014) Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study. Mod Pathol 27:1632-40. doi: https:\/\/doi.org\/10.1038\/modpathol.2014.74","journal-title":"Mod Pathol"},{"key":"9668_CR60","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000381454","volume":"101","author":"I Rapa","year":"2015","unstructured":"Rapa I, Votta A, Felice B, Righi L, Giorcelli J, Scarpa A, Speel EJ, Scagliotti GV, Papotti M, Volante M (2015) Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression. Neuroendocrinology 101:246-55. doi: https:\/\/doi.org\/10.1159\/000381454","journal-title":"Neuroendocrinology"},{"key":"9668_CR61","doi-asserted-by":"publisher","first-page":"101042831772841","DOI":"10.1177\/1010428317728417","volume":"39","author":"P Di Fazio","year":"2017","unstructured":"Di Fazio P, Maass M, Roth S, Meyer C, Grups J, Rexin P, Bartsch DK, Kirschbaum A (2017) Expression of hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors of the lung. Tumour Biol 39:1010428317728417. doi: https:\/\/doi.org\/10.1177\/1010428317728417","journal-title":"Tumour Biol"},{"key":"9668_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000461582","volume":"106","author":"T Yoshimoto","year":"2018","unstructured":"Yoshimoto T, Motoi N, Yamamoto N, Nagano H, Ushijima M, Matsuura M, Okumura S, Yamaguchi T, Fukayama M, Ishikawa Y (2018) Pulmonary Carcinoids and Low-Grade Gastrointestinal Neuroendocrine Tumors Show Common MicroRNA Expression Profiles, Different from Adenocarcinomas and Small Cell Carcinomas. Neuroendocrinology 106:47-57. doi: https:\/\/doi.org\/10.1159\/000461582","journal-title":"Neuroendocrinology"},{"key":"9668_CR63","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12022-020-09626-1","volume":"31","author":"D Narayanan","year":"2020","unstructured":"Narayanan D, Mandal R, Hardin H, Chanana V, Schwalbe M, Rosenbaum J, Buehler D, Lloyd RV (2020) Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms. Endocr Pathol 31:254-263. doi: https:\/\/doi.org\/10.1007\/s12022-020-09626-1","journal-title":"Endocr Pathol"},{"key":"9668_CR64","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canlet.2004.10.027","volume":"223","author":"RJ Rieker","year":"2005","unstructured":"Rieker RJ, Aulmann S, Penzel R, Schnabel PA, Blaeker H, Esposito I, Morresi-Hauf A, Otto HF, Hecker E, Dienemann H, Schirmacher P, Mechtersheimer G (2005) Chromosomal imbalances in sporadic neuroendocrine tumours of the thymus. Cancer Lett 223:169-74. doi: https:\/\/doi.org\/10.1016\/j.canlet.2004.10.027","journal-title":"Cancer Lett"},{"key":"9668_CR65","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/modpathol.3800246","volume":"18","author":"CC Pan","year":"2005","unstructured":"Pan CC, Jong YJ, Chen YJ (2005) Comparative genomic hybridization analysis of thymic neuroendocrine tumors. Mod Pathol 18:358-64. doi: https:\/\/doi.org\/10.1038\/modpathol.3800246","journal-title":"Mod Pathol"},{"key":"9668_CR66","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/gcc.22183","volume":"53","author":"P Str\u00f6bel","year":"2014","unstructured":"Str\u00f6bel P, Zettl A, Shilo K, Chuang WY, Nicholson AG, Matsuno Y, Gal A, Laeng RH, Engel P, Capella C, Marino M, Chan JK, Rosenwald A, Travis W, Franks TJ, Ellenberger D, Schaefer IM, Marx A (2014) Tumor genetics and survival of thymic neuroendocrine neoplasms: a multi-institutional clinicopathologic study. Genes Chromosomes Cancer 53:738-49. doi: https:\/\/doi.org\/10.1002\/gcc.22183","journal-title":"Genes Chromosomes Cancer"},{"key":"9668_CR67","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1530\/ERC-15-0092","volume":"22","author":"M Kidd","year":"2015","unstructured":"Kidd M, Drozdov I, Modlin I (2015) Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status. Endocr Relat Cancer 22:561-75. doi: https:\/\/doi.org\/10.1530\/ERC-15-0092","journal-title":"Endocr Relat Cancer"},{"key":"9668_CR68","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00000658-199807000-00015","volume":"228","author":"BT Teh","year":"1998","unstructured":"Teh BT, Zedenius J, Kyt\u00f6l\u00e4 S, Skogseid B, Trotter J, Choplin H, Twigg S, Farnebo F, Giraud S, Cameron D, Robinson B, Calender A, Larsson C, Salmela P (1998) Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg 228:99-105. doi: https:\/\/doi.org\/10.1097\/00000658-199807000-00015","journal-title":"Ann Surg"},{"key":"9668_CR69","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1210\/jc.2002-021314","volume":"88","author":"F Gibril","year":"2003","unstructured":"Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, Reynolds JC, Louie A, Entsuah LK, Huang K, Asgharian B, Jensen RT (2003) Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 88:1066-81. doi: https:\/\/doi.org\/10.1210\/jc.2002-021314","journal-title":"J Clin Endocrinol Metab"},{"key":"9668_CR70","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1677\/erc.0.0100437","volume":"10","author":"PD Leotlela","year":"2003","unstructured":"Leotlela PD, Jauch A, Holtgreve-Grez H, Thakker RV (2003) Genetics of neuroendocrine and carcinoid tumours. Endocr Relat Cancer 10:437-50. doi: https:\/\/doi.org\/10.1677\/erc.0.0100437","journal-title":"Endocr Relat Cancer"},{"key":"9668_CR71","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1046\/j.1440-1827.1999.00971.x","volume":"49","author":"T Fujii","year":"1999","unstructured":"Fujii T, Kawai T, Saito K, Hishima T, Hayashi Y, Imura J, Hironaka M, Hosoya Y, Koike M, Fukayama M (1999) MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation. Pathol Int 49:968-73. doi: https:\/\/doi.org\/10.1046\/j.1440-1827.1999.00971.x","journal-title":"Pathol Int"},{"key":"9668_CR72","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12020-010-9324-6","volume":"38","author":"RX Liu","year":"2010","unstructured":"Liu RX, Wang WQ, Ye L, Bi YF, Fang H, Cui B, Zhou WW, Dai M, Zhang J, Li XY, Ning G (2010) p21-activated kinase 3 is overexpressed in thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome and participates in cell migration. Endocrine 38:38-47. doi: https:\/\/doi.org\/10.1007\/s12020-010-9324-6","journal-title":"Endocrine"},{"key":"9668_CR73","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1677\/ERC-08-0325","volume":"16","author":"YF Bi","year":"2009","unstructured":"Bi YF, Liu RX, Ye L, Fang H, Li XY, Wang WQ, Zhang J, Wang KK, Jiang L, Su TW, Chen ZY, Ning G (2009) Gene expression profiles of thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome reveal novel molecular mechanism. Endocr Relat Cancer 16:1273-82. doi: https:\/\/doi.org\/10.1677\/ERC-08-0325","journal-title":"Endocr Relat Cancer"},{"key":"9668_CR74","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/978-3-030-54391-4_18","volume-title":"The Spectrum of Neuroendocrine Neoplasia","author":"O Mete","year":"2021","unstructured":"Mete O, Hannah-Shmouni F, Kim R, Stratakis CA. Inherited Neuroendocrine Neoplasms. In: Asa SL, La Rosa S, Mete O. (eds) The Spectrum of Neuroendocrine Neoplasia. Springer, Cham. 2021, pp: 409-459"},{"key":"9668_CR75","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/jcm7090280","volume":"7","author":"SL Asa","year":"2018","unstructured":"Asa SL, Ezzat S, Mete O (2018) The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations. J Clin Med 7:280. doi: https:\/\/doi.org\/10.3390\/jcm7090280","journal-title":"J Clin Med"},{"key":"9668_CR76","doi-asserted-by":"publisher","unstructured":"Kimura N. Dopamine \u03b2-hydroxylase: An Essential and Optimal Immunohistochemical Marker for Pheochromocytoma and Sympathetic Paraganglioma (2021) Endocr Pathol. Epub ahead of print. doi: https:\/\/doi.org\/10.1007\/s12022-020-09655-w.","DOI":"10.1007\/s12022-020-09655-w"},{"key":"9668_CR77","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/cncy.21765","volume":"124","author":"K Duan","year":"2016","unstructured":"Duan K, Mete O (2016) Algorithmic approach to neuroendocrine tumors in targeted biopsies: Practical applications of immunohistochemical markers. Cancer Cytopathol 124:871-884. doi: https:\/\/doi.org\/10.1002\/cncy.21765","journal-title":"Cancer Cytopathol"},{"key":"9668_CR78","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12022-019-9569-4","volume":"30","author":"M Szybowska","year":"2019","unstructured":"Szybowska M, Mete O, Weber E, Silver J, Kim RH (2019) Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway. Endocr Pathol 30:237-245. doi: https:\/\/doi.org\/10.1007\/s12022-019-9569-4","journal-title":"Endocr Pathol"},{"key":"9668_CR79","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","volume":"386","author":"RV Thakker","year":"2014","unstructured":"Thakker RV (2014) Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol 386:2-15. doi: https:\/\/doi.org\/10.1016\/j.mce.2013.08.002","journal-title":"Mol Cell Endocrinol"},{"key":"9668_CR80","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/cen.13480","volume":"87","author":"L Ye","year":"2017","unstructured":"Ye L, Wang W, Ospina NS, Jiang L, Christakis I, Lu J, Zhou Y, Zhu W, Cao Y, Wang S, Perrier ND, Young WF Jr, Ning G, Wang W (2017) Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single-centre study, systematic review and meta-analysis. Clin Endocrinol (Oxf) 87:706-716. doi: https:\/\/doi.org\/10.1111\/cen.13480","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9668_CR81","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000435921","volume":"103","author":"DK Bartsch","year":"2016","unstructured":"Bartsch DK, Albers MB, Lopez CL, Apitzsch JC, Walthers EM, Fink L, Fendrich V, Slater EP, Waldmann J, Anlauf M (2016) Bronchopulmonary Neuroendocrine Neoplasms and Their Precursor Lesions in Multiple Endocrine Neoplasia Type 1. Neuroendocrinology 103:240-7. doi: https:\/\/doi.org\/10.1159\/000435921","journal-title":"Neuroendocrinology"},{"key":"9668_CR82","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12672-016-0269-y","volume":"7","author":"I Christakis","year":"2016","unstructured":"Christakis I, Qiu W, Silva Figueroa AM, Hyde S, Cote GJ, Busaidy NL, Williams M, Grubbs E, Lee JE, Perrier ND (2016) Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center. Horm Cancer 7:279-87. doi: https:\/\/doi.org\/10.1007\/s12672-016-0269-y","journal-title":"Horm Cancer"},{"key":"9668_CR83","doi-asserted-by":"publisher","first-page":"R121","DOI":"10.1530\/ERC-13-0482","volume":"21","author":"CR Pieterman","year":"2014","unstructured":"Pieterman CR, Conemans EB, Dreijerink KM, de Laat JM, Timmers HT, Vriens MR, Valk GD (2014) Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis. Endocr Relat Cancer 21:R121-42. doi: https:\/\/doi.org\/10.1530\/ERC-13-0482","journal-title":"Endocr Relat Cancer"},{"key":"9668_CR84","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/cncr.20825","volume":"103","author":"N Sachithanandan","year":"2005","unstructured":"Sachithanandan N, Harle RA, Burgess JR (2005) Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1. Cancer 103:509-15. doi: https:\/\/doi.org\/10.1002\/cncr.20825","journal-title":"Cancer"},{"key":"9668_CR85","first-page":"1616","volume":"26","author":"A Murat","year":"1997","unstructured":"Murat A, Heymann MF, Bernat S, Dupas B, Delajartre AY, Calender A, Despins P, Michaud JL, Giraud S, Le Bodic MF, Charbonnel B (1997) Tumeurs neuro-endocrines thymiques et bronchiques au cours des n\u00e9oplasies endocrines multiples de type 1. GENEM1 [Thymic and bronchial neuroendocrine tumors in multiple endocrine neoplasia type 1. GENEM1]. Presse Med 26:1616-21.","journal-title":"Presse Med"},{"key":"9668_CR86","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1210\/jc.2014-1560","volume":"99","author":"JM de Laat","year":"2014","unstructured":"de Laat JM, Pieterman CR, van den Broek MF, Twisk JW, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR, Valk GD (2014) Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients. J Clin Endocrinol Metab 99:3325-33. doi: https:\/\/doi.org\/10.1210\/jc.2014-1560","journal-title":"J Clin Endocrinol Metab"},{"key":"9668_CR87","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML; Endocrine Society","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML; Endocrine Society (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990-3011. doi: https:\/\/doi.org\/10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab"},{"key":"9668_CR88","doi-asserted-by":"crossref","unstructured":"Duan K, Mete O (2017) Hereditary Endocrine Tumor Syndromes: The Clinical and Predictive Role of Molecular Histopathology. AJSP: Reviews & Reports 22: 246\u2013268. Doi not available","DOI":"10.1097\/PCR.0000000000000206"},{"key":"9668_CR89","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1210\/jc.2019-00082","volume":"104","author":"A Frederiksen","year":"2019","unstructured":"Frederiksen A, Rossing M, Hermann P, Ejersted C, Thakker RV, Frost M (2019) Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases. J Clin Endocrinol Metab 104:3637-3646. doi: https:\/\/doi.org\/10.1210\/jc.2019-00082","journal-title":"J Clin Endocrinol Metab"},{"key":"9668_CR90","doi-asserted-by":"publisher","first-page":"e00092","DOI":"10.1002\/edm2.92","volume":"2","author":"V Larouche","year":"2019","unstructured":"Larouche V, Akirov A, Thain E, Kim RH, Ezzat S (2019) Co-occurrence of breast cancer and neuroendocrine tumours: New genetic insights beyond Multiple Endocrine Neoplasia syndromes. Endocrinol Diabetes Metab 2:e00092. doi: https:\/\/doi.org\/10.1002\/edm2.92","journal-title":"Endocrinol Diabetes Metab"},{"key":"9668_CR91","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1378\/chest.13-0811","volume":"144","author":"LR Young","year":"2013","unstructured":"Young LR, Deutsch GH, Bokulic RE, Brody AS, Nogee LM (2013) A mutation in TTF1\/NKX2.1 is associated with familial neuroendocrine cell hyperplasia of infancy. Chest 144:1199-1206. doi: https:\/\/doi.org\/10.1378\/chest.13-0811","journal-title":"Chest"},{"key":"9668_CR92","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1513\/AnnalsATS.201603-155BC","volume":"13","author":"RJ Nevel","year":"2016","unstructured":"Nevel RJ, Garnett ET, Worrell JA, Morton RL, Nogee LM, Blackwell TS, Young LR (2016) Persistent Lung Disease in Adults with NKX2.1 Mutation and Familial Neuroendocrine Cell Hyperplasia of Infancy. Ann Am Thorac Soc 13:1299-304. doi: https:\/\/doi.org\/10.1513\/AnnalsATS.201603-155BC","journal-title":"Ann Am Thorac Soc"},{"key":"9668_CR93","first-page":"7533","volume":"8","author":"WA Hassan","year":"2015","unstructured":"Hassan WA, Udaka N, Ueda A, Ando Y, Ito T (2015) Neoplastic lesions in CADASIL syndrome: report of an autopsied Japanese case. Int J Clin Exp Pathol 8:7533-9.","journal-title":"Int J Clin Exp Pathol"},{"key":"9668_CR94","doi-asserted-by":"publisher","unstructured":"Pedro J, Cunha FM, Neto V, Hespanhol V, Martins DF, Guimar\u00e3es S, Varela A, Carvalho D (2020) Coexistence of DIPNECH and carotid body paraganglioma: is it just a coincidence? Endocrinol Diabetes Metab Case Rep 2020:EDM19\u20130141. doi: https:\/\/doi.org\/10.1530\/EDM-19-0141.","DOI":"10.1530\/EDM-19-0141"},{"key":"9668_CR95","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/annonc\/mdv041","volume":"26","author":"ME Caplin","year":"2015","unstructured":"Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A, Rossi RE, Travis WD; ENETS consensus conference participants (2015) Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol 26:1604-20. doi: https:\/\/doi.org\/10.1093\/annonc\/mdv041","journal-title":"Ann Oncol"},{"key":"9668_CR96","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1634\/theoncologist.2018-0520","volume":"24","author":"A Dasari","year":"2019","unstructured":"Dasari A, Bergsland EK, Benson AB, Cai B, Huynh L, Totev T, Shea J, Duh MS, Neary MP, Dagohoy CG, Shih BE, Maurer VE, Chan J, Kulke MH (2019) Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review Study. Oncologist 24:1066-1075. doi: https:\/\/doi.org\/10.1634\/theoncologist.2018-0520","journal-title":"Oncologist"},{"key":"9668_CR97","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1210\/jc.2018-01931","volume":"104","author":"T Vesterinen","year":"2019","unstructured":"Vesterinen T, Leijon H, Mustonen H, Remes S, Knuuttila A, Salmenkivi K, Vainio P, Arola J, Haglund C (2019) Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors. J Clin Endocrinol Metab 104:2083-2093. doi: https:\/\/doi.org\/10.1210\/jc.2018-01931","journal-title":"J Clin Endocrinol Metab"},{"key":"9668_CR98","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ejca.2016.11.034","volume":"75","author":"I Sullivan","year":"2017","unstructured":"Sullivan I, Le Teuff G, Guigay J, Caramella C, Berdelou A, Leboulleux S, D\u00e9andr\u00e9is D, Hadoux J, Ducreux M, Duvillard P, Adam J, Scoazec JY, Baudin E, Planchard D (2017) Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids. Eur J Cancer 75:259-267. doi: https:\/\/doi.org\/10.1016\/j.ejca.2016.11.034","journal-title":"Eur J Cancer"},{"key":"9668_CR99","doi-asserted-by":"publisher","first-page":"R391","DOI":"10.1530\/ERC-20-0227","volume":"27","author":"L de Mestier","year":"2020","unstructured":"de Mestier L, Couvelard A, Blazevic A, Hentic O, de Herder WW, Rebours V, Paradis V, Ruszniewski P, Hofland LJ, Cros J (2020) Critical appraisal of MGMT in digestive NET treated with alkylating agents. Endocr Relat Cancer 27:R391-R405. doi: https:\/\/doi.org\/10.1530\/ERC-20-0227","journal-title":"Endocr Relat Cancer"},{"key":"9668_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000500158","volume":"110","author":"S Vatrano","year":"2020","unstructured":"Vatrano S, Giorcelli J, Votta A, Capone G, Izzo S, Gatti G, Righi L, Napoli F, Scagliotti G, Papotti M, Volante M, Rapa I (2020) Multiple Assays to Determine Methylguanine-Methyltransferase Status in Lung Carcinoids and Correlation with Clinical and Pathological Features. Neuroendocrinology 110:1-9. doi: https:\/\/doi.org\/10.1159\/000500158","journal-title":"Neuroendocrinology"},{"key":"9668_CR101","doi-asserted-by":"publisher","first-page":"153","DOI":"10.21873\/cgp.20073","volume":"15","author":"D Moris","year":"2018","unstructured":"Moris D, Ntanasis-Stathopoulos I, Tsilimigras DI, Adam MA, Yang C-FJ, Harpole D, Theocharis S (2018) Insights into Novel Prognostic and Possible Predictive Biomarkers of Lung Neuroendocrine Tumors. Cancer Genomics Proteomics 15:153-163. doi: https:\/\/doi.org\/10.21873\/cgp.20073","journal-title":"Cancer Genomics Proteomics"},{"key":"9668_CR102","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.lungcan.2019.07.016","volume":"135","author":"H Xie","year":"2019","unstructured":"Xie H, Boland JM, Maleszewski JJ, Aubry MC, Yi ES, Jenkins SM, Koepplin JW, Terra SBSP, Mansfield AS, Roden AC (2019) Expression of delta-like protein 3 is reproducibly present in a subset of small cell lung carcinomas and pulmonary carcinoid tumors. Lung Cancer 135:73-79. doi: https:\/\/doi.org\/10.1016\/j.lungcan.2019.07.016","journal-title":"Lung Cancer"},{"key":"9668_CR103","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.18632\/oncotarget.2092","volume":"5","author":"EP Samartzis","year":"2014","unstructured":"Samartzis EP, Gutsche K, Dedes KJ, Fink D, Stucki M, Imesch P (2014) Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition. Oncotarget 5:5295-303. doi: https:\/\/doi.org\/10.18632\/oncotarget.2092","journal-title":"Oncotarget"},{"key":"9668_CR104","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nm.3799","volume":"21","author":"BG Bitler","year":"2015","unstructured":"Bitler BG, Aird KM, Garipov A, Li H, Amatangelo M, Kossenkov AV, Schultz DC, Liu Q, Shih IeM, Conejo-Garcia JR, Speicher DW, Zhang R (2015) Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers. Nat Med 21:231-8. doi: https:\/\/doi.org\/10.1038\/nm.3799","journal-title":"Nat Med"},{"key":"9668_CR105","doi-asserted-by":"publisher","first-page":"13837","DOI":"10.1038\/ncomms13837","volume":"7","author":"CT Williamson","year":"2016","unstructured":"Williamson CT, Miller R, Pemberton HN, Jones SE, Campbell J, Konde A, Badham N, Rafiq R, Brough R, Gulati A, Ryan CJ, Francis J, Vermulen PB, Reynolds AR, Reaper PM, Pollard JR, Ashworth A, Lord CJ (2016) ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A. Nat Commun 7:13837. doi: https:\/\/doi.org\/10.1038\/ncomms13837","journal-title":"Nat Commun"},{"key":"9668_CR106","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41591-018-0012-z","volume":"24","author":"J Shen","year":"2018","unstructured":"Shen J, Ju Z, Zhao W, Wang L, Peng Y, Ge Z, Nagel ZD, Zou J, Wang C, Kapoor P, Ma X, Ma D, Liang J, Song S, Liu J, Samson LD, Ajani JA, Li GM, Liang H, Shen X, Mills GB, Peng G (2018) ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade. Nat Med 24:556-562. doi: https:\/\/doi.org\/10.1038\/s41591-018-0012-z","journal-title":"Nat Med"},{"key":"9668_CR107","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk O, Yang Z, Tang LH, Hruban RH, Adsay V, McCall CM, Krasinskas AM, Jang KT, Frankel WL, Balci S, Sigel C, Klimstra DS (2015) The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol 39:683-90. doi: https:\/\/doi.org\/10.1097\/PAS.0000000000000408","journal-title":"Am J Surg Pathol"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-021-09668-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-021-09668-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-021-09668-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T07:55:22Z","timestamp":1671436522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-021-09668-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["9668"],"URL":"https:\/\/doi.org\/10.1007\/s12022-021-09668-z","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,27]]},"assertion":[{"value":"21 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}